Chronic myelocytic leukemia as a secondary malignant condition in a patient receiving prolonged chemotherapy for ovarian carcinoma.
D000230:Adenocarcinoma / Q000150:complications*; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications*; D010051:Ovarian Neoplasms / Q000150:complications*
D000970:Antineoplastic Agents